TrianglePUBLICATIONS · 11745872
Efficacy of ifosfamide and doxorubicin given as a phase II "window" in children with newly diagnosed metastatic rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study Group.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Med Pediatr Oncol
- Publication date
- 2001 Nov
- First author
- Sandler E
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Sandler E
- type
- Author
- name
- Lyden E
- type
- Author
- name
- Ruymann F
- type
- Author
- name
- Maurer H
- type
- Author
- name
- Wharam M
- type
- Author
- name
- Parham D
- type
- Author
- name
- Link M
- type
- Author
- name
- Crist W
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Sandler E
- type
- Author
- name
- Lyden E
- type
- Author
- name
- Ruymann F
- type
- Author
- name
- Maurer H
- type
- Author
- name
- Wharam M
- type
- Author
- name
- Parham D
- type
- Author
- name
- Link M
- type
- Author
- name
- Crist W
- type
- Author
- bibliography ids
- nci-bib-bee3ca355610b18d55badae4
- book metadata
- content sha256
- c1f7d5f5a40fc73cb51b55c0f85e40852548904b3ebebfffa201d4f560074c3a
- document type
- citation
- dois
- 10.1002/mpo.1227
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:11745872
- immutable id
- pubmed:11745872@c1f7d5f5a40fc73cb51b55c0f85e40852548904b3ebebfffa201d4f560074c3a
- journal
- abbreviation
- Med Pediatr Oncol
- issn electronic
- Source null
- issn print
- 0098-1532
- issue
- 5
- name
- Medical and pediatric oncology
- nlm unique id
- 7506654
- pages
- 442-8
- volume
- 37
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 11745872
- provenance
- batch id
- d4e82e28940c878dd0a2
- provider
- NCBI PubMed ESummary
- record sha256
- 8c0e5a0bc18ebfb4cf0fb60b197e4d1bf967254a9b93f6622e9f47ab71a01784
- response sha256
- 257c7530b1505623f6712628a73c1e9b8b3119838f4ec701e62de2dab9d87468
- retrieved at
- 2026-09-09T23:45:44.017762+00:00
- publication date
- display
- 2001 Nov
- precision
- month
- year
- 2001
- publication types
- Clinical Trial
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Research Support, U.S. Gov't, P.H.S.
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Efficacy of ifosfamide and doxorubicin given as a phase II "window" in children with newly diagnosed metastatic rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study Group.
Preserved source evidence · Not medical advice